Cargando…
Generalized pustular psoriasis with a novel mutation of interleukin-36 receptor antagonist, responding to methotrexate
Autores principales: | Teoh, Yee-Leng, Tay, Yong-Kwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802561/ https://www.ncbi.nlm.nih.gov/pubmed/27051681 http://dx.doi.org/10.1016/j.jdcr.2014.12.007 |
Ejemplares similares
-
Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis
por: Liu, Zhi-Jie, et al.
Publicado: (2020) -
Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond
por: Sugiura, Kazumitsu
Publicado: (2022) -
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
por: Shao, Shuai, et al.
Publicado: (2022) -
Generalized pustular psoriasis in infant with heterozygous mutation in the IL36RN gene successfully treated with infliximab
por: Glerup, Mia, et al.
Publicado: (2014) -
Case report: Infantile generalized pustular psoriasis with IL36RN and CARD14 gene mutations
por: Tong, Xinyun, et al.
Publicado: (2023)